Present Scenario in Pharma Research and Business Management
Authors/Creators
- 1. MBBS, MS in Business Analytics, Senior Statistical Programmer
- 2. M.D (General Medicine)
- 3. M.Pharm (Quality Assurance).
- 4. M.Pharm (Pharma Sales & Marketing)
- 5. MBA, (Pharma Sales & Marketing)
- 6. M.Sc. Chemistry (Quality Control)
- 7. M. Sc. Biotech ( Medical Coding)
- 8. Student of Doctor of Healthcare Management, The Masterminds International University, Kingdom Of Eswatini (Swaziland), Africa
Description
The Indian pharmaceutical industry truly came into its own after gaining independence. Today, it stands as the fourth largest market for generic pharmaceuticals globally. In terms of volume, it ranks fourth, while in terms of value, it holds the thirteenth position among global pharmaceutical markets. Furthermore, the industry demonstrates consistent growth.
To uphold the quality, safety, and effectiveness of medicinal products for sales, imports, and manufacturing, a robust regulatory system is in place. The regulatory framework governing India’s pharmaceutical industry is among the most stringent in the country. Given the rapid and continuous changes in this field, it is crucial to comprehend the regulatory landscape. Regulatory bodies bear the responsibility of ensuring a steady supply of high-quality medications at affordable prices to the Indian population, which places a significant burden on them.
Abstract (English)
The Indian pharmaceutical industry truly came into its own after gaining independence. Today, it stands as the fourth largest market for generic pharmaceuticals globally. In terms of volume, it ranks fourth, while in terms of value, it holds the thirteenth position among global pharmaceutical markets. Furthermore, the industry demonstrates consistent growth.
To uphold the quality, safety, and effectiveness of medicinal products for sales, imports, and manufacturing, a robust regulatory system is in place. The regulatory framework governing India’s pharmaceutical industry is among the most stringent in the country. Given the rapid and continuous changes in this field, it is crucial to comprehend the regulatory landscape. Regulatory bodies bear the responsibility of ensuring a steady supply of high-quality medications at affordable prices to the Indian population, which places a significant burden on them.
Files
IJTPR,Vol13,Issue6,Article38.pdf
Files
(447.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:d6f85e4b965205afda30a0bd6378e71e
|
447.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-06-27
Software
References
- 1. Milind S, Sandeep J, Chirag S, Venkata PP. Pharmaceutical Research in India: Current Status and Opportunities. Proc Indian Natn Sci Acad. 2020; 86(2): 1015-1022. 2. Shaik SB, Shakeel SM., Nagabhushanam MV, Nagarjuna R, Brahmaiah B. The Assessment of Current Regulatory Guidelines for Biosimilars- A Global Scenario. World Journal of Pharmaceutical Research. 2016; (6): 351-369. 3. Kataria BC, Panchal PJ, Panchasara AK, Pandya AS, Parmar MR. Comparison of new drug approval by regulatory agencies of US, EU and India. International Journal of basic and clinical pharmacology. 2016; 51. 4. De Meyer A, Nakane J, Miller, JM, Ferdows K. Flexibility: The next competitive battle: the manufacturing futures survey. Strategic Management Journal. 1989; 10(2): 135–144. 5. Ikeda K, Takeoka S. Evaluation of Recently Discontinued Drugs to Identify Factors Contributing to their Failure and to Improve the Efficiency of Pharmaceutical Drug Development. J Clin Med Ther. 2018; 31:4. 6. Babler S. Pharmaceutical and biomedical project management in a challenging global environment. Hoboken, NJ: John Wiley & Sons, Inc. 2010. 7. Kaplan RS, Norton DP. Using the balanced scorecard as a strategic management system. Harvard Business Review. 2007; 74(1): 75–85. 8. Statista. Pharmaceutical market worldwide revenue 2001-2016 Statistic. 2017. 9. IBEF. Indian Pharmaceuticals Industry Analysis: A Sectoral Presentation. 2018.